Publications by authors named "Esther Exposito-Palomo"
Coagulase-negative staphylococci (CoNS) are currently considered typical microorganisms causing infective endocarditis (IE) in patients with prosthetic valves. The objective was to determine variables associated with IE in patients with CoNS bacteremia. We performed an analysis of the clinical characteristics of patients with CoNS bacteremia admitted to a university hospital in Madrid (Spain) from 2021 to December 2022 according to the occurrence of IE.
View Article and Find Full Text PDFInteractions between anti-hypertensive agents (ACEI), comorbidities, inflammation, and stress status may impact hospital stay duration in COVID-19 patients. This retrospective study analyzed epidemiological data, comorbidities, metabolic/inflammatory markers, and clinical information from 165 SARS-CoV-2 positive patients. In a multiple linear regression model, an IL-6 higher than 100 mg/L, glucose at admission (baseline levels at the hospital entry), and the interaction between ACEI administration and LDH predicted the days of hospital admission (P < 0.
View Article and Find Full Text PDFArticle Synopsis
- COVID-19 manifests through various symptoms affecting respiratory, gastrointestinal, and other systems, with links to obesity, diabetes, and cardiovascular issues exacerbating the condition.
- This study analyzed 165 patients diagnosed with COVID-19 pneumonia to assess their metabolic status and predict health outcomes, noting common comorbidities like hypertension, dyslipidemia, obesity, and diabetes.
- Findings indicate that obesity significantly increases the risk of ICU admission and longer hospital stays, highlighting associations between body mass index, blood glucose levels, and mortality rates during hospitalization.
Background: Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2) infection elicits inflammatory manifestations that relate with a "cytokine storm."
Objective: The aim of this research was to assess the role of circulating interleukin 6 (IL-6) levels and other inflammatory markers in patients with coronavirus disease 2019 (COVID-19) on metabolic functions and accompanying clinical complications. .